Report Highlights

Healthcare Simulation Games in the U.S.: Competitive Overview

The U.S. market is concentrated at the hardware layer and fragmented at the software layer. Laerdal Medical and CAE Healthcare hold the largest installed bases in nursing and medical education, while 3D Systems through Simbionix leads procedural surgical simulators. Domestic firms such as Gaumard Scientific and Simulab Corporation win on faculty relationships and local service coverage, advantages international rivals find costly to replicate. Competitive advantage here rests less on game design than on accreditation alignment, since curricula must map to ACGME competencies to win institutional purchase orders.

Competitive advantage in the United States is determined by three factors: accreditation alignment, interoperability with learning management systems, and clinical validation evidence. Vendors that publish outcome studies from partner medical schools win renewals, while pure entertainment-style studios are excluded from most procurement processes. Pricing is set through enterprise site licences rather than per-seat sales, which favors incumbents with large installed hardware bases and established service technicians across regional hospital networks.

Demand Drivers Shaping Healthcare Simulation Games in the U.S.

Clinical workforce pressure is the strongest demand driver. The American Association of Colleges of Nursing reports that tens of thousands of qualified applicants are turned away each year because schools lack faculty, pushing programs toward simulation to substitute for supervised clinical hours. Laerdal Medical and Gaumard Scientific benefit most, since high-fidelity manikins and their scenario libraries are the default substitute. Surgical residency growth adds demand for procedural rehearsal, favoring 3D Systems' Simbionix and Osso VR.

Reimbursement changes are opening a second channel. The FDA authorized EndeavorRx from Akili Interactive in 2020 as a prescription video game for pediatric attention-deficit disorder, and CMS introduced billing codes for digital mental health treatment devices in its 2025 Physician Fee Schedule. Vendors that secure payment codes first capture payer-funded volume. Health systems also demand return-on-investment evidence, so vendors with peer-reviewed outcome data, including Level Ex and SimX, gain procurement preference over newer entrants.

Competitive Restraints and Market Challenges

Price competition is intensifying at the content layer. Free or low-cost scenario libraries from academic consortia and open-source engines compress license fees, leaving commercial developers to justify premiums through assessment analytics. Talent is a second constraint. Studios capable of pairing game engine expertise with clinical accuracy are scarce, and salaries for clinically validated developers exceed general game-industry benchmarks, raising unit costs for smaller vendors.

Regulatory compliance adds cost for vendors that cross into clinical claims. Products marketed for diagnosis or treatment require FDA clearance, and a De Novo or 510(k) pathway can take a year or more, while HIPAA obligations apply to any game that stores learner or patient performance data. Infrastructure gaps compound this. Rural and critical access hospitals often lack bandwidth and VR-ready space, which limits the addressable base for Osso VR and SimX outside metropolitan academic centers.

Growth Opportunities for Market Players

Rural and community hospital training represents the largest untapped segment. Mobile simulation units, which carry headsets, manikins and cloud-hosted scenarios on trailers, let vendors such as CAE Healthcare reach facilities that cannot host fixed labs. Vendors that package this model under per-visit pricing gain access to budgets that academic medical centers never reach. Federal workforce programs administered through HRSA rural health initiatives provide grant funding that can cover equipment and training fees, which strengthens the case for subscription offerings tied to grant cycles.

Emergency preparedness and military-civilian contracts form a second opportunity. The Administration for Strategic Preparedness and Response and state health departments fund mass-casualty and pandemic response exercises, and Gaumard Scientific and Laerdal Medical compete for these contracts through standardized scenario packages. Patient-facing therapy games, particularly those sold to Medicare Advantage plans, remain underserved by simulation incumbents and represent the clearest entry point for software-first entrants.

Market at a Glance

Leading Market Participants

• Laerdal Medical
• CAE Healthcare
• Gaumard Scientific
• Simulab Corporation
• 3D Systems
• SimX
• Osso VR
• Level Ex
• Akili Interactive
• Surgical Science

Regulatory and Policy Environment

The Food and Drug Administration governs the clinical boundary. Software that delivers therapy falls under medical device rules, and the 21st Century Cures Act exempts certain clinical decision support software but not therapy-delivering games. Akili's EndeavorRx pathway established precedent for prescription digital therapeutics, which vendors now use as a template for submissions. Products that remain purely educational avoid premarket review, which is why most simulation vendors keep training claims separate from patient-facing claims in their marketing.

Accreditation and payment rules shape purchasing more than procurement statutes do. The Accreditation Council for Graduate Medical Education sets competency frameworks that residency programs use to justify simulation spend, and Joint Commission standards require documented training for staff competencies. CMS HCPCS codes G0552 through G0554 for digital mental health treatment devices, effective in 2025, create a payment pathway for approved applications. HIPAA and state privacy laws govern learner and patient data, adding compliance costs for every vendor.

Competitive Outlook for Healthcare Simulation Games in the U.S.

Competitive structure will shift toward hybrid platforms by 2032. Vendors that combine physical manikin hardware with cloud-hosted VR and analytics will displace single-modality players, and Laerdal Medical and CAE Healthcare have the installed base to lead this transition. Consolidation will also reach the software layer as venture-backed studios face financing constraints and seek acquirers among hardware incumbents.

Market share will concentrate around vendors with accreditation-aligned content and reimbursable outcomes. Digital therapeutics firms that secure CMS payment codes will grow faster than education-only studios, but their share will remain small relative to hardware-anchored training contracts through the forecast period. By 2032, the top five vendors will hold a clear majority of institutional spend, while the remaining field competes for specialized surgical and therapy niches.